Previous 10 | Next 10 |
2024-01-04 12:27:00 ET More on Portage Biotech Seeking Alpha’s Quant Rating on Portage Biotech Historical earnings data for Portage Biotech Financial information for Portage Biotech For further details see: Portage Biotech to halt iNKT drug program...
2024-01-04 10:00:14 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resources Company will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-onc...
Portage Biotech Inc. (PRTG) is expected to report $-0.27 for Q2 2024
2023-11-28 16:21:57 ET More on Portage Biotech Portage Biotech stock sheds after announcing $6M registered direct offering Seeking Alpha’s Quant Rating on Portage Biotech Historical earnings data for Portage Biotech Financial information for Portage Bi...
WESTPORT, Conn., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported financial results for the fiscal quarter ended September 30, 2023. ...
Updated data support the proof of concept of using an iNKT engager monotherapy (PORT-2) to induce immune response for patients with non-small cell lung cancer (NSCLC) and melanoma Strong academic interest in the design of the Adenosine 2A(A2A) and Adenosine 2B(A2B) trial for patients wi...
2023-10-31 16:21:05 ET More on Portage Biotech Portage Biotech stock sheds after announcing $6M registered direct offering Seeking Alpha’s Quant Rating on Portage Biotech For further details see: Portage Biotech files to sell 9.63M shares for holders
2023-09-29 09:04:40 ET More on Portage Biotech Seeking Alpha’s Quant Rating on Portage Biotech Historical earnings data for Portage Biotech Financial information for Portage Biotech For further details see: Portage Biotech announces $6M registered ...
WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, today announced that it has entered into a definitive agreement for the purchase ...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 17.9% to $0.1179 on volume of 290,472,504 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 7.1% to $0.6248 on volume of 223,394,331 shares GameStop Corporation (GME) rose 21.0% to $28...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 22.3% to $0.12231 on volume of 147,748,197 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 11.8% to $0.6524 on volume of 95,235,738 shares AMC Entertainment Holdings Inc. Class A (AM...
A look at the top 10 most actives in the United States Novo Integrated Sciences Inc. (NVOS) rose 132.8% to $1.05 on volume of 308,155,573 shares Greenwave Technology Solutions Inc. (GWAV) fell 7.9% to $0.0387 on volume of 278,348,616 shares Faraday Future Intelligent Electric Inc. (FFIE) ...